FDA Inspection
Lilly del Caribe, IncLilly del Caribe, Inc – FDA Inspection, Jan 30, 2026
Record Details
This FDA Inspection record concerns Lilly del Caribe, Inc, with an inspection on January 30, 2026, issued by the San Juan District Office, covering human drugs.
View Company Profile
ID · d9a41b15-225e-4c51-bfaf-91cb7e3c3d83
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1300794
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lilly del Caribe, Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 16, 2024 | Not classified | San Juan District Office | |
| February 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 21, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lilly del Caribe, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.